Skip banner
HomeHow Do I?Site MapHelp
Return To Search FormFOCUS
Search Terms: personal w/5 information w/5 privacy, House or Senate or Joint

Document ListExpanded ListKWICFULL format currently displayed

Previous Document Document 195 of 261. Next Document

More Like This
Copyright 1999 Federal Document Clearing House, Inc.  
Federal Document Clearing House Congressional Testimony

July 20, 1999

SECTION: CAPITOL HILL HEARING TESTIMONY

LENGTH: 2977 words

HEADLINE: TESTIMONY July 20, 1999 PAUL D. CLAYTON SENIOR INFORMATICIST HOUSE WAYS AND MEANS HEALTH PATIENT CONFIDENTIALITY

BODY:
Statement of Paul D. Clayton, Ph.D., Senior Informaticist, Intermountain Health Care, Salt Lake City, Utah, on behalf of the American Hospital Association Testimony Before the Subcommittee on Health of the House Committee on Ways and Means Hearing on Confidentiality of Health Information July 20, 1999 Mr. Chairman, I am Paul D. Clayton, PhD, senior informaticist at Intermountain Health Care (IHC) in Salt Lake City, UT. IHC is an integrated health care delivery system that operates in Utah, Idaho and Wyoming. The IHC system includes 23 hospitals, 78 clinics and physician offices, 23 outpatient primary care centers, 16 home health agencies, and 400 employed physicians. In addition, our system operates a large Health Plans Division with enrollment of 475,000 directly insured, plus 430,000 who use our networks through other insurers. I am testifying today on behalf of the American Hospital Association (AHA), which represents nearly 5,000 hospitals, health systems, networks, and other providers of care. We appreciate this opportunity to present our views on an issue important to hospitals, health systems, and the patients they serve: the confidentiality of protected health information. PROTECTING PATIENTS' TRUST Every day, thousands of Americans walk through the doors of America's hospitals. Each and every one of them provides caregivers information of the most intimate nature. They provide this information under the assumption that it will remain confidential. It is critical that this trust be maintained. Otherwise, patients may be less forthcoming with information about their conditions and needs - information that is essential for physicians and other caregivers to know in order to keep people well, ease pain, and treat and cure illness. If caregivers are not able to obtain and share patients' medical histories, test results, physician observations, and other important information, patients will not receive the most appropriate, high-quality care possible. Our members consider themselves guardians of this information. That is why AHA has long supported the passage of strong federal legislation to establish uniform national standards for all who use patients' personal medical information - what we refer to as protected health information. We have been asked to focus our comments today on how hospitals use and protect patient information to enhance the quality of the patient care they deliver. Our longstanding principles for the confidentiality of health information cover a broader range of critical patient privacy issues, and we have attached them for your information. We will measure any federal privacy legislation against these principles in their entirety. Confidentiality of health information is an issue that affects all of us personally. We live in a time of rapidly advancing technological improvement, when the world seems to get smaller as computers get more powerful and databases get bigger. This technological change can be positive - it has led to significant improvements for both health care providers and their patients - but it worries people who are justifiably concerned about how information about them will be used. In health care, we must take the steps necessary to protect that information from those who would misuse it. We need strong, uniform federal legislation to do it. First and foremost, because we as hospitals and health systems put our patients first, we must restore and maintain people's trust in the privacy and confidentiality of their personal health information. Federal legislation can do this by establishing a uniform national standard for the protection of this information - including genetic information - a standard that balances patient privacy with the need for information to flow freely among health care providers. PRIVACY AND HEALTH CARE OPERATIONS Health care is increasingly provided by groups and systems of providers, as opposed to individual providers. These new systems create opportunities for real improvements, but they rely heavily on a free flow of information among providers. Patient confidentiality is of the utmost importance. But in order to ensure that care can be coordinated and the patient's experience is as seamless as possible, information must be accessible to all providers who treat the patient. There is very little disagreement that access to information is important in the delivery of care to patients, and in the system of payment for that care. Controversy has developed, however, over the definition of "health care operations" - those essential functions performed by providers to ensure that they maintain and improve the quality of the care they deliver, train current and future caregivers, and adhere to the laws and regulations that govern these daily activities. AHA believes that protected health information must be available to providers so that these functions can be performed efficiently and effectively. INFORMATION BREEDS HEALTH CARE SUCCESS STORIES At IHC, we believe, as does the AHA, that individuals who are making decisions that affect the health of another person must know about past medical and family history, allergies to drugs, previous diagnostic results, current medications, previous surgeries or therapies, and chronic and acute problems. Because the primary caregiver is not present all the time, because others are asked for consultive opinions, and because humans have limited memory, access to medical record information dramatically affects the level of care that can be provided. In some cases, the absence of information increases the cost of diagnosis and treatment by causing tests to be repeated because the results of an earlier tests are not available. Among the benefits of improved access are an enhanced ability to generate bills and collect payment, and to transmit information to payers and analyze the costs of providing care. Care is also improved when a caregiver has access to the medical record. A physician or other health care worker who knows what drugs a patient is taking, a list of previous problems, a history of family predisposition to certain illnesses, and current laboratory results, will make better decisions about how to diagnose and treat a patient. At IHC, we have, for the past 14 years, used clinical data systems to substantially improve patient care in a wide range of circumstances. Here are a few examples. Improved timing of delivery of pre-operative antibiotics to prevent serious post-operative wound infections. Our wound infection rate fell from 1.8 percent to 0.4 percent, representing, at just one of our 23 hospitals, more than 50 patients per year who now do not suffer serious, potentially life- threatening infections. We also saved the cost of treating those infections, which, at that hospital, was estimated at $750,000. Improved support for inpatient prescriptions. A computerized order entry system warns physicians, at the time they place the order, of potential allergies and drug-to-drug interactions. It also calculates ideal dose levels, using the patient's age, weight, gender, and estimates of patient-specific drug-absorption and excretion rates, based on laboratory values. That system has reduced allergic reactions and overdoses by more than two-thirds. Improved management of mechanical respirators for patients with acute respiratory distress syndrome. In the most seriously ill category of these patients, mortality rates fell from more than 90 percent to less than 60 percent. Improved management of diabetic patients in an outpatient setting. The proportion of patients brought to normal blood sugar levels improved from less than 30 percent to more than 70 percent. Major studies of diabetes demonstrate that this kind of shift in blood sugar translates to significantly less blindness, kidney failure, amputation and death. Others indicate it should reduce the cost of treatment for diabetes patients by about $1,000 per patient per year. Improved treatment of community-acquired pneumonia. By helping physicians more appropriately identify patients who needed hospitalization, choose appropriate initial antibiotics, and start antibiotic therapy quickly, we were able to reduce inpatient mortality rates by 26 percent. That translates into about 20 lives saved at 10 small rural IHC hospitals when we first worked on this aspect of care. It also reduced costs by more than 12 percent. Accountability for health care delivery performance. IHC has begun to assemble and report medical outcomes, patient satisfaction outcomes, and cost outcomes for major clinical care processes that make up more than 90 percent of our total care delivery activities. We aggregate and report those data at the level of individual physicians; practice groups; hospitals; regions; and for our entire system. We use the results to hold each health care professional and our system accountable for the care we deliver to our patients, and to set and achieve care improvement goals. We believe that this system will eventually allow IHC to accurately report our performance at community, state and national levels, and help individuals and groups make better health care choices. All of the examples above were successful because patient information - not just individual patient information, but also information about populations of patients - was available, and flowed smoothly among the providers that needed it. POTENTIAL DISRUPTIONS TO THE FREE FLOW OF INFORMATION There are two provisions in various patient privacy proposals that could have the unintended effect of placing enormous barriers in front of providers' ability to appropriately use information for these and similar purposes. The first is what has been referred to as the "opt out," where patients would have the ability to prevent providers from sharing the patient's information regardless of how important such a disclosure might be. The problem with such an opt out is that it sacrifices hospitals' ability to deliver high-quality care to the individual involved, as well as to other patients. For example, IHC's laboratory analyzers feed directly into our computer system. When we committed to that link, we not only significantly improved our ability to deliver excellent care to all of our patients, but also necessarily lost our ability to process blood laboratory tests without using the electronic medical record. In addition, a patient who might decide to prevent his or her records from being shared among providers is, effectively, reducing the quality of health care he or she may receive in the future. This is because, without access to that patient's records, providers simply cannot make well-informed decisions. At the same time, removing the patient's treatment information as a factor in overall health care statistics degrades the overall integrity of the health care information flow. In other words, if less is known, less can be learned, and the overall quality of care could be affected. The second potential problem we see being discussed is a requirement, included in several patient privacy proposals, that providers must limit the scope of medical information disclosures to no more than what is necessary for the specific purpose of the disclosure. Penalties would be levied, according to the proposals, presumably if too much information were to be provided. Health care providers, who deal with a mountain of information every day, simply cannot be expected to determine the exact need for every piece of information and the exact measurement of information that may be required to meet that need. The threat of penalties makes the proposals worse, and is sure to inhibit the free flow of important information. In addition, proper safeguards should already be in place that would prevent the misuse of patient information, so that requiring providers to justify each disclosure would be unnecessary. Proper policies and procedures will ensure that patient information is used only where it is needed to benefit the health care services provided to an individual patient, or to improve the overall health care system through statistics and analysis. SAFEGUARDING PATIENT INFORMATION IHC and the AHA support strong, uniform federal confidentiality standards that buttress our health care delivery and clinical research work. IHC has placed appropriate protection of patient confidentiality and privacy at the forefront of our institutional values. Those values complement a parallel mission to provide the best possible health maintenance and disease treatment to those who trust their care to our hands. Achieving this requires the use of population-level patient data as well as individual patient data. IHC uses enforceable corporate policy to maintain confidentiality not just for patients, but for health care professionals and employees as well, in those areas that are clearly health care delivery operations (such as direct patient care delivery; billing for services; quality review of individual patient records, including mortality and morbidity conferences; resource planning; unit performance evaluation; quality improvement and disease management; and retrospective epidemiologic evaluations of program performance). The core of these policies and enforcement activities include: We require every employee, health care professional, researcher or volunteer to sign a confidentiality agreement stating that they will only look at or share information for the specific purpose of performing their health care delivery assignment on behalf of our patients. We require each new employee to undergo training in IHC confidentiality policies, which are set forth in a manual that numbers more than 60 pages and represents more than five years of discussion and cross-testing. We impose consequences - including termination - for improper use or handling of confidential information. To the extent that we have implemented an electronic medical record, we are able to monitor access to patient records (an ability not available for paper records). We use that system as one important method of monitoring and enforcing our confidentiality policy. We utilize software controls, including warnings on log-on screens, unique log-on passwords, and computerized audit trails. In the near future, we hope to bring on-line the ability of all patients to review a list of every individual who has accessed their electronic medical record for any purpose. We segregate our electronic databases, separating patient identifiers from the remainder of the clinical record. Outside of direct patient care and individual record review for quality assurance, most health care delivery operations do not require access to identifiable data. IHC's data access policies regulate access to patient information using strict "need to know" criteria by job description. While we afford tight access control to all of our information, the identifiable portion of the record receives the highest level of protection. We are studying ways to segregate the core clinical record itself, so that particularly sensitive information - for example, HIV status, reproductive history, or mental health status - are only available on a strict "need to know" basis, even to the front-line care delivery team. In addition, we require full institutional review board (IRB) review, approval and on-going oversight for any research project that involves experimental therapy, patient randomization among treatment options, or patient contact for research purposes. Indeed, the IHC system has 12 IRBs, but we do not look to them as our sole - or even our primary - means to protect confidentiality. Most of the risks to patient confidentiality come in day-to-day care, as physicians and nurses routinely access identifiable patient medical records, both paper and electronic, to deliver care. Instead, we rely upon the extensive array of enforceable policies and procedures listed above. If IRB review of each of these health care operations were required, many - if not most - of the operational care delivery and health outcome improvements described earlier could not function on a day-to-day basis. The volume of review would be staggering, far beyond the capacity of any reasonable system of individual review and follow-up oversight. CONCLUSION As an integrated health care delivery system, IHC is responsible for the health outcomes of the patients who seek care from our system. In order to treat our patients and improve the health outcomes of the entire population we serve, we must be able to share information among IHC entities - our physicians, our hospitals, and our health plans. IHC has developed state-of-the- art electronic medical records and common databases to facilitate this communication, to make sure our physicians have complete information when treating patients . We have put in place an extensive array of enforceable confidentiality protections that are constantly updated and improved. We urge this panel to ensure that confidentiality legislation does not unintentionally prevent the creation of these common internal, operational databases, or limit the types of data that can be shared within an integrated delivery system. Such action would severely limit a health system's ability to measure and improve the health care it delivers. The outstanding care that physicians, nurses and others deliver at IHC and in hospitals and health systems across America relies more and more on coordination of care and on effective quality improvement. Individually identifiable health information is integral to such operations, and the free flow of this information - properly safeguarded from misuse - is critical to our ability to continue providing high-quality health care for patients and communities.

LOAD-DATE: July 21, 1999




Previous Document Document 195 of 261. Next Document


FOCUS

Search Terms: personal w/5 information w/5 privacy, House or Senate or Joint
To narrow your search, please enter a word or phrase:
   
About LEXIS-NEXIS® Congressional Universe Terms and Conditions Top of Page
Copyright © 2002, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.